getstoredimage

Remember the questionable study claiming glyphosate boosts cancer risk 41%? Lead author reasserts her claim, EPA refutes it, and we take a second look

Sheppard and her co-authors are intent on favoring data that appears to support the existence of a risk from glyphosate ...
gillam

Anti-glyphosate activist Carey Gillam ‘collaborated’ with attorney charged in extortion plot

In a press release, the [Department of Justice] said that one of the lead plaintiffs' attorneys, Timothy Litzenburg, who helped ...
Issue SocialMediaAttentionSpan px

Podcast: Meet Mary Mangan—the biologist who crashes anti-GMO events and debunks junk science on Twitter

Mangan discusses her unique approach to spreading science literacy ...
maxresdefault

Time Magazine’s coverage of glyphosate-cancer trial is ‘crying out for balance,’ biologist says

TIME magazine has a story on DeWayne ‘Lee’ Johnston who took Monsanto to court claiming RoundUp caused his non-Hodgkin lymphoma ...
nader slider

Viewpoint: Challenging the hypocrisy of GMO critic Carey Gillam

Carey Gillam is a former journalist for Reuters, and is currently the research director for US Right to Know (US ...
maxresdefault

Viewpoint: How anti-GMO activist-journalist Carey Gillam primes the glyphosate litigation pump

The Guardian published an article by Sam Levin and Carey Gillam [on October 7] about the “new era of cancer lawsuits ...
gillam

Ex-Reuters reporter Carey Gillam: Anti-Monsanto crusader or obsessed anti-GMO activist?

[Carey Gillam] the longtime reporter, who now works for a consumer advocacy group, is pegged by her detractors as an activist at ...
image

Viewpoint: Activists promotion of ‘fog of misinformation’ about GMOs challenges science communicators

Activists spend all day peddling nonsense. If they spent that kind of time on constructive issues…sigh. [A] local radio station ...
gillam

Review of Whitewash (or Hogwash?): Carey Gillam’s glyphosate book betrays science, undermines our understanding of cancer

Last fall a new book hit the shelves, timed to coincide with public hearings on the European Union’s re-authorization of ...